Subscribe to Newsletter

SeungSuh (Stanley) Hong

The Power List 2017 – Business Captains

SeungSuh (Stanley) Hong

Senior Advisor, Celltrion Healthcare Co. Ltd

Stanley joined Celltrion in 2002 and was involved in the development of Remsima, the first biosimilar monoclonal antibody to be approved by the European Medicines Agency. He was President and CEO of Celltrion until December 2015.

Part of the Power List 2017

Our Top 100 into 4 categories

Go to The Power List 2017

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine